Pfizer (PFE)

Cost of Revenue

$18.27B

TTM · Period ending: · USD

PFE logo

PFE Cost of Revenue

Latest reported$18.27B
PFE TTM Cost of Revenue ($0.00 → $18.27B)
High-resolution chart · PNG

PFE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
18,267,000,000
19,408,000,000
18,565,000,000
18,088,000,000
20,847,000,000
20,654,000,000
21,147,000,000
24,942,000,000
28,614,000,000
28,169,000,000
29,738,000,000
32,048,000,000
28,434,000,000
32,905,000,000
37,753,000,000
37,531,000,000
41,397,000,000
40,176,000,000
34,376,000,000
27,389,000,000
19,390,000,000
14,227,000,000
12,005,000,000
11,930,000,000
12,868,000,000
13,922,000,000
14,740,000,000
15,419,000,000
15,551,000,000
15,902,000,000
16,034,000,000
16,124,000,000
16,157,000,000
15,902,000,000
15,803,000,000
15,598,000,000
15,600,000,000
14,942,000,000
14,166,000,000
13,396,000,000
11,654,000,000
10,660,000,000
9,647,000,000
8,938,000,000
9,087,000,000
9,369,000,000
9,576,000,000
9,669,000,000
9,588,000,000
9,368,000,000
9,975,000,000
10,353,000,000
10,731,000,000
11,241,000,000
11,563,000,000
12,299,000,000
13,313,000,000
14,366,000,000
15,085,000,000
15,459,000,000
15,676,000,000
15,666,000,000
16,279,000,000
15,932,000,000
13,825,000,000
11,786,000,000
8,888,000,000
6,668,000,000
7,001,000,000
7,534,000,000
8,112,000,000
9,022,000,000
11,518,000,000
11,338,000,000
11,239,000,000
10,831,000,000
8,175,000,000
7,856,000,000
7,942,000,000
8,070,000,000
8,016,000,000
8,307,000,000
8,525,000,000
8,536,000,000
8,268,000,000
7,939,000,000
7,542,000,000
8,559,000,000
10,285,000,000
10,560,000,000
9,831,000,000
6,786,000,000
4,734,000,000
3,904,000,000
4,045,000,000
5,200,000,000
5,063,000,000
5,016,000,000
5,034,000,000
4,761,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.